RemovedRisk Factors
The Company may be unable to effectuate the termination of its frozen primary defined benefit plan (the “Plan”) on favorable terms or at all.
Read it in 10-K Feb 18, 2025 at sec.govopen_in_new
RemovedRisk Factors
In August 2024, the Company executed an amendment to commence the process of terminating the Company’s Plan, as further described in Note 7, Retirement Plans, to the audited Consolidated Financial Statements. The Plan’s benefit obligation is expected to be settled by offering lump sum distributions to participants, followed by the purchase of annuity contracts to transfer the Plan’s remaining obligation to a third party. As settlement of the obligations will be funded with Plan assets, the Company expects to make a cash contribution to fully fund the Plan in 2025. The cash contribution amount will depend upon the nature and timing of participant lump sum settlements and prevailing market conditions. Finalization of the Plan termination is subject to certain conditions, including regulatory review, and the Company has the ability to change the effective date of the termination or revoke the decision to terminate the Plan.
Read it in 10-K Feb 18, 2025 at sec.govopen_in_new
RewordedRisk Factors
On May 27, 2021, March 13, 2025, the Company amended and restated its credit agreement dated as of September 30, 2016 (as in effect prior to such amendment and restatement, the “Credit Agreement,” and the Credit Agreement, as so amended and restated, the “Amended and Restated Credit Agreement”), by and among the Company, the lenders party thereto from time to time and JPMorgan Chase Bank, N.A., as administrative agent and collateral agent, to, among other things, to provide for a $200.0 $115.0 million delayed-draw term loan A facility (the “Term Loan A Facility”), extend the maturity of the establish a $300.0 million revolving facility (the “Revolving Facility,” and, together Facility”) with a maturity date of March 13, 2030 to replace the Term Loan A Facility, entire amount of the “Credit Facilities”) to May 27, 2026 revolving facility and modify the financial maintenance and negative covenants in the Amended and Restated Credit Agreement. Agreement, among other things.
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
RewordedRisk Factors
The Company may be forced to delay commercial release of its services until any discovered problems are corrected and, in some cases, may need corrected, resort to implement enhancements manual processes for customer service and support functions or modifications lose access to correct errors tools that the Company does not detect until after deployment of its services. provide strategic information for decision making.
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
RewordedRisk Factors
A decline in If the number of Company’s retention rates are lower than anticipated or referrals could require decline, the Company could be required to devote substantially more resources to the sales and marketing of its services, services and products, which would increase costs, potentially lead to a decline in net sales, slow the Company’s growth and negatively impact its the Company’s business, results of operations, financial position and cash flows.
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
RewordedRisk Factors
In addition, DFIN’s systems leverage DFIN leverages third-party outsourcing arrangements, technology integrations across its systems, which expedites the Company’s responsiveness facilitate analytics that inform strategic decisions, but exposes information to additional access points.
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
RewordedRisk Factors
Changes to health care regulations in the U.S. and internationally internationally, as well as the average age and claim history of the Company’s employee base, may also increase impact the cost of providing such benefits.
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
RewordedRisk Factors
The risk of a security cybersecurity breach or disruption, particularly through cyber attack or cyber intrusion, disruption has increased as the number, intensity and sophistication of attempted attacks and intrusions from around the world have increased increased, including those utilizing AI capabilities, and the Company has in the past and may in the future be subject to security breaches.
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
RewordedRisk Factors
The Company continues to invest substantially all of its capital expenditures budget on software development, including the development of software solutions for both investment companies and capital markets, most recently with the functionality developed in the new Venue platform, the Arc Suite for the Tailored Shareholder Reporting (“TSR”) regulations, required starting in 2024, regulations and the launch of cloud-based ActiveDisclosure in 2021 and the ongoing development of additional features thereafter, including the ability to file transactional deals utilizing ActiveDisclosure.
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
RewordedRisk Factors
If competitors introduce technologies are further developed to provide client clients alternative means to produce and file documents to meet their regulatory obligations, obligations that they prefer, and the Company does not develop products or provide services to compete with such new technologies in a timely and cost-effective manner, the Company’s business may be adversely affected.
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
RewordedRisk Factors
The Company’s business may be adversely affected if it fails to adapt to technological changes and address the changing demands of clients, including new technologies enabling clients those related to produce and file documents on their own. AI.
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
RewordedRisk Factors
The priorities of the current U.S. administration may impact have impacted SEC rulemaking, causing proposed rules such as climate, proxy voting reform private fund reporting on Form PF, or other topics to be delayed, withdrawn or adopted in a form that is materially different from the Company’s expectation.
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
RewordedRisk Factors
There can be no assurance that clients will continue to use DFIN’s services and products to meet their ongoing needs, particularly in the face of competitors’ services and products offerings, or that their needs for interest in those services will not be impacted by regulatory changes. changes or perception of the regulatory environment.
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
RewordedRisk Factors
In 2020, LSC, which separated from RRD at the same time as DFIN, LSC filed for business reorganization under Chapter 11 of the U.S.
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
AddedMD&A
In August 2024, the Company executed an amendment to commence the process of terminating the Company’s primary defined benefit plan (the “Plan”). During the year ended December 31, 2025, the Company settled the Plan obligations through a combination of lump sum payments to certain Plan participants and the purchase of a non-participating irrevocable group annuity contract (the “Plan Settlement”). In connection with the Plan Settlement, the Company made an $11.3 million, net cash contribution to fully fund the Plan.
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
AddedMD&A
As a result of the Plan Settlement, the Company remeasured the Plan’s assets and obligations and recognized a non-cash settlement charge of $82.8 million during the year ended December 31, 2025, due to the recognition of unrealized accumulated Plan losses previously reported within accumulated other comprehensive loss on the audited Consolidated Balance Sheets. The Plan Settlement was recorded within Corporate.
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
AddedMD&A
Year Ended December 31, 2025 2024 $ Change % Change (in millions, except percentages) Net sales $ 230.0 $ 213.6 $ 16.4 7.7% Segment Adjusted EBITDA 75.0 63.5 11.5 18.1% Segment Adjusted EBITDA margin 32.6% 29.7%
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
AddedMD&A
Year Ended December 31, 2025 2024 $ Change % Change (in millions, except percentages) Net sales $ 296.2 $ 321.7 $ (25.5) (7.9 Segment Adjusted EBITDA 113.8 110.9 2.9 2.6 Segment Adjusted EBITDA margin 38.4% 34.5%
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
AddedMD&A
Year Ended December 31, 2025 2024 $ Change % Change (in millions, except percentages) Net sales $ 128.4 $ 116.1 $ 12.3 10.6% Segment Adjusted EBITDA 50.3 39.7 10.6 26.7% Segment Adjusted EBITDA margin 39.2% 34.2%
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
AddedMD&A
Year Ended December 31, 2025 2024 $ Change % Change (in millions, except percentages) Net sales $ 112.4 $ 130.5 $ (18.1) (13.9 Segment Adjusted EBITDA 39.6 41.5 (1.9) (4.6 Segment Adjusted EBITDA margin 35.2% 31.8%
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
AddedMD&A
Year Ended December 31, 2025 2024 $ Change % Change (in millions, except percentages) Unallocated expenses $ 38.9 $38.3 $0.6 1.6%
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
AddedMD&A
On July 4, 2025, an act to provide for reconciliation pursuant to title II of H. Con. Res. 14, commonly referred to as the “One Big Beautiful Bill Act” (the “Act”) was signed into law. The Act changes the timing of certain tax deductions, including depreciation expense, research and development (R&D) expenditures and interest expense. Aspects of the Act became effective for the Company in the third quarter of 2025, with certain additional impacts coming into effect in 2026 and beyond. The Company expects certain provisions of the Act to change the timing of cash tax payments related to 2025 and future periods, but does not expect the enacted legislation to have a material impact on its income tax expense in future periods.
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
AddedMD&A
Adjustments to reconcile net earnings to net cash provided by operating activities:
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
AddedMD&A
Pension and other postretirement benefits plans contributions (13.1) (1.9) (11.2)
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
AddedMD&A
•Pension and other postretirement benefits plans contributions decreased operating cash flows by $11.2 million more during the year ended December 31, 2025, primarily due to the Company’s $11.3 million, net cash contribution to fully fund the Plan in connection with the Plan Settlement.
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
AddedMD&A
Quantitative Assessment for Impairment—As of October 31, 2025, the Company performed a quantitative assessment for the CM-SS, CM-CCM and IC-SS reporting units. The analysis performed included estimating the fair value of the reporting units using both the income and market approaches. The income approach requires management to estimate a number of factors, including projected future operating results, anticipated future cash flows, discount rates and the allocation of shared assets and certain corporate expenses. The market approach estimates fair value using comparable marketplace fair value data from within a comparable industry grouping. The income and market approaches were weighted equally to estimate the concluded fair value of the reporting unit.
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
RemovedMD&A
The Company operates its business through four operating and reportable segments: Capital Markets – Software Solutions, Capital Markets – Compliance and Communications Management, Investment Companies – Software Solutions and Investment Companies – Compliance and Communications Management. The Company’s operating segments are components of the business for which discrete financial information is available and reviewed regularly by the Company’s chief operating decision maker (“CODM”), the Company’s CEO, to assess segment performance and to make decisions regarding the allocation of resources.
Read it in 10-K Feb 18, 2025 at sec.govopen_in_new
RemovedMD&A
Year Ended December 31, 2024 2023 (in millions) Net cash provided by operating activities $ 171.1 $ 124.0 Net cash used in investing activities (53.3) (51.3) Net cash used in financing activities (82.1) (84.6) Effect of exchange rate on cash and cash equivalents (1.5) 0.8 Net increase (decrease) in cash and cash equivalents $ 34.2 $ (11.1)
Read it in 10-K Feb 18, 2025 at sec.govopen_in_new
RemovedMD&A
The Company has disposed of the eBrevia business, which closed on December 1, 2023, resulting in net cash proceeds of $0.5 million and Edgar Online (“EOL”) business, which closed on November 9, 2022, resulting in net cash proceeds of $3.3 million.
Read it in 10-K Feb 18, 2025 at sec.govopen_in_new
RemovedMD&A
Qualitative Assessment for Impairment—As of October 31, 2024, the Company performed a qualitative assessment for the CM-SS, CM-CCM and IC-SS reporting units, to determine whether it was more likely than not that the fair values of the reporting units were less than their carrying values. In performing this analysis, the Company considered various qualitative factors, including economic conditions, industry and market considerations, cost factors, overall financial performance of the reporting unit and other entity and reporting unit specific events.
Read it in 10-K Feb 18, 2025 at sec.govopen_in_new
RemovedMD&A
The Company’s defined benefit plans are frozen. No new employees are permitted to enter the Company’s frozen plans and participants do not earn additional benefits. Benefits are generally based upon years of service and compensation. These defined benefit retirement income plans are funded in conformity with the applicable government regulations. The Company funds at least the minimum amount required for all funded plans using actuarial cost methods and assumptions acceptable under government regulations.
Read it in 10-K Feb 18, 2025 at sec.govopen_in_new
RemovedMD&A
In August 2024, the Company executed an amendment to commence the process of terminating the Company’s primary defined benefit plan (the “Plan”), as further described in Note 7, Retirement Plans, to the audited Consolidated Financial Statements. The Plan’s benefit obligation is expected to be settled by offering lump sum distributions to participants, followed by the purchase of annuity contracts to transfer the Plan’s remaining obligation to a third party. As settlement of the obligations will be funded with Plan assets, the Company expects to make a cash contribution to fully fund the Plan in 2025. The cash contribution amount will depend upon the nature and timing of participant lump sum settlements and prevailing market conditions. As termination of the Plan is considered probable, the Plan’s actuarial assumptions as of December 31, 2024 reflect the expected Plan termination. Finalization of the Plan termination is subject to certain conditions, including regulatory review, and the Company has the ability to change the effective date of the termination or revoke the decision to terminate the Plan.
Read it in 10-K Feb 18, 2025 at sec.govopen_in_new
RemovedMD&A
The annual income and expense amounts relating to the pension plan are based on calculations which include various actuarial assumptions including mortality expectations, discount rates and expected long-term rates of return. The Company reviews its actuarial assumptions on an annual basis as of December 31 (or more frequently if a significant event requiring remeasurement occurs) and modifies the assumptions based on current rates and trends when it is appropriate to do so. The effects of modifications are recognized immediately on the audited Consolidated Balance Sheets, but are amortized into operating earnings over future periods, with the deferred amount recorded in accumulated other comprehensive loss. The Company believes that the assumptions utilized in recording its obligations under its plans are reasonable based on its experience, market conditions and input from its actuaries and investment advisors. The weighted-average discount rate to determine the pension benefit obligation at December 31, 2024 was 5.3%.
Read it in 10-K Feb 18, 2025 at sec.govopen_in_new
RemovedMD&A
A 1.0% change in the discount rates as of December 31, 2024 would (decrease) increase the accumulated benefit obligation and projected benefit obligation:
Read it in 10-K Feb 18, 2025 at sec.govopen_in_new
RemovedMD&A
1.0% 1.0% Increase Decrease (in millions) Accumulated benefit obligation $ (13.0) $15.2 Projected benefit obligation $ (13.0) $15.2
Read it in 10-K Feb 18, 2025 at sec.govopen_in_new
RemovedMD&A
The Company has a risk management approach for its pension plan assets. The overall investment objective of this approach is to further reduce the risk of significant decreases in the plan’s funded status by allocating a larger portion of the plan’s assets to investments expected to hedge the impact of interest rate risks on the Plan’s obligation.
Read it in 10-K Feb 18, 2025 at sec.govopen_in_new
RemovedMD&A
The expected long-term rate of return for the Plan assets is based upon many factors including expected asset allocations, historical asset returns, current and expected future market conditions and risk. In addition, the Company considered the impact of the current interest rate environment on the expected long-term rate of return for certain asset classes, particularly fixed income. The expected long-term rate of return on plan assets assumption used to calculate net pension plan income for the year ended December 31, 2024 was 6.0%. In accordance with the Company’s intent to settle the Plan, the current target asset allocation is 100% fixed income investments to reduce the risk of significant decreases in the funded status. The expected long-term rate of return on plan assets assumption used to calculate net pension plan income for the year ending December 31, 2025 is 5.3% and reflects the effective discount rate required to settle the Plan’s benefit obligations.
Read it in 10-K Feb 18, 2025 at sec.govopen_in_new
RemovedMD&A
A 0.25% change in the expected long-term rate of return on plan assets as of December 31, 2024 would increase (decrease) net pension plan income for the year ending December 31, 2025 as follows:
Read it in 10-K Feb 18, 2025 at sec.govopen_in_new
RewordedMD&A
Credit Agreement—On May 27, 2021, March 13, 2025, the Company amended and restated its credit agreement dated as of September 30, 2016 (as in effect prior to such amendment and restatement, the “Credit Agreement,” and the Credit Agreement, as so amended and restated, the “Amended and Restated Credit Agreement”), by and among the Company, the lenders party thereto from time to time and JPMorgan Chase Bank, N.A., as administrative agent and collateral agent, to, among other things, to provide for a $200.0 $115.0 million delayed-draw term loan A facility (the “Term Loan A Facility”) (bearing interest at Facility”), establish a rate equal to the sum of the London Interbank Offered Rate (“LIBOR”) plus a margin ranging from 2.00% to 2.50% based upon the Company's Consolidated Net Leverage Ratio), extend the maturity of the $300.0 million revolving credit facility (the “Revolving Facility”) with a maturity date of March 13, 2030 to May 27, 2026 replace the entire amount of the revolving facility and modify the financial maintenance and negative covenants in the Amended and Restated Credit Agreement. Agreement, among other things.
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
RewordedMD&A
Year Ended December 31, 2025 Year Ended December 31, 2024 Year Ended December 31, 2023 Pre-tax After-tax Pre-tax After-tax (in millions) Restructuring, impairment and other charges, net $ 10.4 $ 7.8 $ 6.6 $ 5.0 $ 9.8 $ 7.5 Share-based compensation expense 31.4 22.6 25.2 14.8 22.5 13.3 Pension plan settlement charge 82.8 60.3 — — Loss on debt extinguishment 0.2 0.1 — — Accelerated rent benefit (1.6) (1.2) — — Gain on sale sales of long-lived assets (0.5) (0.4) (9.8) (7.0) (0.8) (0.6) Non-income tax, net (0.3) (0.2) (1.1) (0.7) (0.9) (0.6) Gain on investments in equity securities (0.1) (0.1) (0.4) (0.3) (7.0) (5.1) (Gain) loss Gain on sale of a business — — (0.4) (0.3) 6.1 — Accelerated rent expense — — 3.7 3.2 Disposition-related expenses — — 0.3 0.2
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
RewordedMD&A
Depreciation and amortization of $60.2 $59.3 million for the year ended December 31, 2024 increased $3.5 2025 decreased $0.9 million, or 6.2%, 1.5%, as compared to the year ended December 31, 2023, 2024, primarily due to higher software amortization expense driven by additional software development and $2.8 million of accelerated amortization expense related to discontinued software, software recorded during the year ended December 31, 2024 and lower depreciation expense of $1.5 million, partially offset by a decrease in other intangible asset higher software amortization expense. expense of $3.4 million, driven by additional software development.
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
RewordedMD&A
Year Ended December 31, 2025 2024 2023 (in millions) Net earnings $ 32.4 $ 92.4 $ 82.2 Restructuring, impairment and other charges, net 10.4 6.6 9.8 Share-based compensation expense 31.4 25.2 22.5 Pension plan settlement charge 82.8 — Accelerated rent benefit (1.6) — Gain on sale sales of long-lived assets (0.5) (9.8) (0.8) Non-income tax, net (0.3) (1.1) (0.9) Gain on investments in equity securities (0.1) (0.4) (7.0) (Gain) loss Gain on sale of a business — (0.4) 6.1 Accelerated rent expense — 3.7 Disposition-related expenses — 0.3 Depreciation and amortization 59.3 60.2 56.7 Interest expense, net 12.9 15.8 12.9 Investment and other income, loss (income), net 2.4 (1.0) (0.8) Income tax expense 10.7 32.7 19.8 Adjusted EBITDA $ 239.8 $ 217.3 $ 207.4
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
RewordedMD&A
Segment Adjusted EBITDA of $119.4 $113.8 million for the year ended December 31, 2023 decreased $22.0 2025 increased $2.9 million, or 15.6%, 2.6%, as compared to the year ended December 31, 2022, 2024, primarily due to lower SG&A expenses of $19.6 million and lower cost of sales volumes, an unfavorable sales mix and higher bad debt expense, of $9.0 million, partially offset by cost control initiatives and lower selling expense as a result net sales of the decrease in sales volumes. $25.5 million.
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
RewordedMD&A
Segment Adjusted EBITDA of $63.5 $75.0 million for the year ended December 31, 2024 2025 increased $18.3 $11.5 million, or 40.5%, 18.1%, as compared to the year ended December 31, 2023, 2024, primarily due to higher net sales volumes, a favorable sales mix, price increases and cost control initiatives, of $16.4 million, partially offset by higher SG&A expenses of $4.5 million, largely driven by higher selling expense, higher incentive compensation expense and higher bad debt expense. expense of $1.1 million, partially offset by cost control initiatives.
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
RewordedMD&A
Net sales of $116.1 $128.4 million for the year ended December 31, 2024 2025 increased $9.3 $12.3 million, or 8.7%, 10.6%, as compared to the year ended December 31, 2023, primarily 2024, due to higher non-TSR-related net sales of $6.5 million, largely driven by price increases, and higher net sales of $5.8 million from the Company’s TSR offering, impacting primarily within ArcReporting and ArcDigital, as well as Arc Suite price increases, partially offset by lower ArcRegulatory volumes. ArcDigital.
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
RewordedMD&A
Factors which could trigger an impairment review include significant underperformance relative to historical or projected future operating results, obsolescence, if client demand for the software does not meet expectations, significant changes in the manner of use of the assets or software, changes in the strategy for the overall business or significant negative industry the cost of developing or economic trends. modifying a software asset significantly exceeds expectations.
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
RewordedMD&A
Segment Adjusted EBITDA of $36.9 $50.3 million for the year ended December 31, 2023 2025 increased $2.8 $10.6 million, or 8.2%, 26.7%, as compared to the year ended December 31, 2022, 2024, primarily due to higher net sales volumes, cost control initiatives and price increases, of $12.3 million, partially offset by higher cost of sales of $3.5 million, largely driven by higher product development costs of $1.4 million and a higher allocation of overhead costs. sales volumes.
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
RewordedMD&A
Segment Adjusted EBITDA margin increased by approximately 340 bps from 29.1% 31.8% for the year ended December 31, 2022 2024 to 33.1% 35.2% for the year ended December 31, 2023, 2025, primarily due to an approximately 240 bps decrease in cost of sales as a favorable sales mix and cost control initiatives, partially offset percentage of net sales, largely driven by a higher lower allocation of overhead costs.
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
RewordedMD&A
The change in the effective income tax rate was primarily driven by a net decrease in valuation allowances, the tax benefit from the loss on the disposition of the eBrevia business recorded in 2023 research and a reduction in favorable return to provision adjustments, development credits and lower pre-tax earnings, partially offset by higher pre-tax earnings. non-deductible compensation.
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new
RewordedMD&A
Print and distribution cost of Net sales of $97.0 $112.4 million for the year ended December 31, 2023 2025 decreased $18.7 $18.1 million, or 16.2%, 13.9%, as compared to the year ended December 31, 2022. 2024, primarily due to lower print and distribution net sales of $14.0 million, largely driven by a decline in compliance volumes.
Read it in 10-K Feb 17, 2026 at sec.govopen_in_new